pharmaLevers GmbH
5 SlideShares 1 Folgen
Personal Information
Unternehmen/Arbeitsplatz
Zürich Area, Switzerland Switzerland
Branche
Medical / Health Care / Pharmaceuticals
Webseite
http://www.pharmalevers.com
Info
Kurt is Principal and Managing Director at pharmaLevers GmbH, a Swiss based Consulting firm. Kurt offers market access and reimbursement consulting for the pharmaceutical, medical device and health care industries. PharmaLevers helps clients to make full use of drug potential by bridging and aligning stakeholder’s value perception. Prior to setting up pharmaLevers Kurt launched several products and managed many national and international clinical trials in the field of Oncology, Hepatitis, HIV and Biotech for a leading global R&D company. His personal initiatives of innovative and unconventional arrangements resulted in accelerated market access of key products. He then made a move to th...
Kontaktdetails
Tags
pharmaceuticals market access health economics pricing & reimbursement drg health insurer atmp switzerland cell-& gene therapy health care budget impact affordability hta healthcare medical devices pharmaceutical clinical pathways artificial intelligence genomics precison medicine regulations pricing pharma life cycle launch excellence kpi's strategy
Mehr anzeigen

Präsentationen

(5)
Alle anzeigen

Swiss triennial Drug Re-valuation

Vor 5 Jahren • 107 Aufrufe

Precicion Medicine - challenges and concepts

Vor 5 Jahren • 78 Aufrufe

Market access quiz 2020 01-guide

Vor 4 Jahren • 105 Aufrufe

Affordability - a new decade

Vor 3 Jahren • 134 Aufrufe

Swiss Cell- & Gene Therapies.pdf

Vor 1 Jahr • 131 Aufrufe
Personal Information
Unternehmen/Arbeitsplatz
Zürich Area, Switzerland Switzerland
Branche
Medical / Health Care / Pharmaceuticals
Webseite
http://www.pharmalevers.com
Info
Kurt is Principal and Managing Director at pharmaLevers GmbH, a Swiss based Consulting firm. Kurt offers market access and reimbursement consulting for the pharmaceutical, medical device and health care industries. PharmaLevers helps clients to make full use of drug potential by bridging and aligning stakeholder’s value perception. Prior to setting up pharmaLevers Kurt launched several products and managed many national and international clinical trials in the field of Oncology, Hepatitis, HIV and Biotech for a leading global R&D company. His personal initiatives of innovative and unconventional arrangements resulted in accelerated market access of key products. He then made a move to th...
Tags
pharmaceuticals market access health economics pricing & reimbursement drg health insurer atmp switzerland cell-& gene therapy health care budget impact affordability hta healthcare medical devices pharmaceutical clinical pathways artificial intelligence genomics precison medicine regulations pricing pharma life cycle launch excellence kpi's strategy
Mehr anzeigen